002317: Guangdong Zhongsheng Pharmaceutical Co., Ltd. - Summary | Jitta

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

CHN:002317

Price
CN¥24.03
Loss Chance
49.2%
4.79JITTA SCORE
512.65%Over Jitta Line
Jitta Ranking
358 / 486
3,525 / 5,282
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (65)
Financial Strength (80)
Return to Shareholders (6)
Competitive Advantage (31)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 90.15% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.79
512.65%
4.36
818.87%
4.22
> 1,000%
Pharmaceuticals
7.05
2.44%
7.28
22.49%
7.98
39.87%
COMPANY DESCRIPTION
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops. It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.